VanEck Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.6M | Sell |
|
|||||
|
2025
Q1 | $68.7M | Sell |
|
|||||
|
2024
Q4 | $64.1M | Buy |
|
|||||
|
2024
Q3 | $71.2M | Buy |
|
|||||
|
2024
Q2 | $67.9M | Sell |
|
|||||
|
2024
Q1 | $63.5M | Sell |
|
|||||
|
2023
Q4 | $70.9M | Buy |
|
|||||
|
2023
Q3 | $53.5M | Sell |
|
|||||
|
2023
Q2 | $57.8M | Sell |
|
|||||
|
2023
Q1 | $55.3M | Buy |
|
|||||
|
2022
Q4 | $47.3M | Sell |
|
|||||
|
2022
Q3 | $50.7M | Buy |
|
|||||
|
2022
Q2 | $45.3M | Buy |
|
|||||
|
2022
Q1 | $37.8M | Sell |
|
|||||
|
2021
Q4 | $35M | Sell |
|
|||||
|
2021
Q3 | $32.5M | Buy |
|
|||||
|
2021
Q2 | $28.5M | Buy |
|
|||||
|
2021
Q1 | $26M | Buy |
|
|||||
|
2020
Q4 | $26.5M | Buy |
|
|||||
|
2020
Q3 | $27.2M | Sell |
|
|||||
|
2020
Q2 | $30.6M | Buy |
|
|||||
|
2020
Q1 | $17.8M | Sell |
|
|||||
|
2019
Q4 | $19.7M | Sell |
|
|||||
|
2019
Q3 | $17.6M | Sell |
|
|||||
|
2019
Q2 | $20.3M | Sell |
|
|||||
|
2019
Q1 | $21.4M | Buy |
|
|||||
|
2018
Q4 | $19.1M | Sell |
|
|||||
|
2018
Q3 | $24.9M | Sell |
|
|||||
|
2018
Q2 | $23.8M | Buy |
|
|||||
|
2018
Q1 | $21.7M | Sell |
|
|||||
|
2017
Q4 | $28.5M | Sell |
|
|||||
|
2017
Q3 | $31.5M | Sell |
|
|||||
|
2017
Q2 | $29.9M | Sell |
|
|||||
|
2017
Q1 | $36.8M | Sell |
|
|||||
|
2016
Q4 | $25.1M | Buy |
|
|||||
|
2016
Q3 | $24.6M | Buy |
|
|||||
|
2016
Q2 | $22.1M | Sell |
|
|||||
|
2016
Q1 | $21.5M | Buy |
|
|||||
|
2015
Q4 | $31.7M | Buy |
|
|||||
|
2015
Q3 | $26.2M | Sell |
|
|||||
|
2015
Q2 | $34.9M | Buy |
|
|||||
|
2015
Q1 | $33.2M | Buy |
|
|||||
|
2014
Q4 | $29.3M | Sell |
|
|||||
|
2014
Q3 | $29.1M | Sell |
|
|||||
|
2014
Q2 | $28.5M | Sell |
|
|||||
|
2014
Q1 | $25.5M | Buy |
|
|||||
|
2013
Q4 | $23.3M | Buy |
|
|||||
|
2013
Q3 | $18.4M | Buy |
|
|||||
|
2013
Q2 | $14.4M | Buy |
|